![Page 1: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/1.jpg)
Harvard Medical School
Coronary MDCTA Applications
Thomas H. Hauser
MD, MMSc, MPH, FACCDirector of Nuclear Cardiology
Beth Israel Deaconess Medical CenterAssistant Professor of Medicine
Harvard Medical SchoolBoston, MA
![Page 2: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/2.jpg)
Harvard Medical School
Outline
• Possible indications for coronary MDCTA• How to approach a coronary MDCTA study
![Page 3: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/3.jpg)
Harvard Medical School
Outline
• Possible indications for coronary MDCTA• How to approach a coronary MDCTA study
![Page 4: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/4.jpg)
Harvard Medical School
Possible Indications for Cardiac CT
• Coronary artery – CAD/Plaque
– Stents
– Grafts
– Anomalous coronaries
• Ventricular size and function
• Valve imaging
• Myocardial perfusion
• Infarct imaging• Cardiac vein imaging
• Congenital heart disease
• Cardiac masses
• Cardiomyopathy
• Pulmonary vein imaging
![Page 5: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/5.jpg)
Harvard Medical School
Detection of CAD
Accuracy investigators, RSNA 2007
![Page 6: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/6.jpg)
Harvard Medical School
Clinical Evaluation of
Coronary CTA
![Page 7: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/7.jpg)
Harvard Medical School
Multi-Center Trial: 16-Slice MDCT
Garcia, M. J. et al. JAMA 2006;296:403-411.
![Page 8: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/8.jpg)
Harvard Medical School
Multi-Center Trials: CORE-64, Accuracy
• CORE-64 reported at AHA 2007 (Toshiba)– 291 patients at 9 institutions
– Sensitivity 85%
– Specificity 90%
– Excluded patients with calcium score >600
• ACCURACY reported at RSNA 2007 (GE)– 229 patients at 16 institutions
– Sensitivity 93%
– Specificity 82%
![Page 9: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/9.jpg)
Harvard Medical School
ACCURACY Trial
J Am Coll Cardiol Budoff et al. online only
![Page 10: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/10.jpg)
Harvard Medical School
Limitations of Coronary CTA
• Coronary Motion • Slab artifacts
– Ventricular Ectopy
– Ventilatory Motion
• Calcium• Stents• Radiation Dose
![Page 11: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/11.jpg)
Harvard Medical School
Coronary Motion
Hoffmann et al, J Nucl Med 2006; 47:797–806
![Page 12: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/12.jpg)
Harvard Medical School
Higher Heart Rate = More Motion
Hoffmann, M. H. K. et al. Radiology 2005;234:86-97
![Page 13: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/13.jpg)
Harvard Medical School
Slab Artifact
Hoffmann et al, J Nucl Med 2006; 47:797–806
![Page 14: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/14.jpg)
Harvard Medical School
Calcium
Hoffmann et al, J Nucl Med 2006; 47:797–806
![Page 15: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/15.jpg)
Harvard Medical School
Calcium
Raff et al, J Am Coll Cardiol 2005;46:552–7
![Page 16: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/16.jpg)
Harvard Medical School
Stents
Gaspar, T. et al. J Am Coll Cardiol 2005;46:1573-1579
![Page 17: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/17.jpg)
Harvard Medical School
Stents
![Page 18: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/18.jpg)
Harvard Medical School
Grafts
![Page 19: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/19.jpg)
Harvard Medical School
Grafts
![Page 20: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/20.jpg)
Harvard Medical School
Grafts
![Page 21: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/21.jpg)
Harvard Medical School
Grafts
![Page 22: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/22.jpg)
Harvard Medical School
Grafts
Vessels Segments Sens Spec
Grafts 109 182 99% 96%
Run-off 109 123 89% 93%
Non-BP 116 288 97% 86%
Malagutti et al. Eur Heart J 2006 epub
![Page 23: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/23.jpg)
Harvard Medical School
Radiation Dose: High
Einstein et al, JAMA. 2007;298:317-323.
![Page 24: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/24.jpg)
Harvard Medical School
Radiation Dose
J Am Coll Cardiol Maruyama et al. 52 (18): 1450
![Page 25: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/25.jpg)
Harvard Medical School
Radiation Dose
J Am Coll Cardiol Maruyama et al. 52 (18): 1450
![Page 26: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/26.jpg)
Harvard Medical School
Problems Correlating with Angiography
• Angiographic stenosis is not perfectly correlated with functional significance– Potential advantages for combining with functional
imaging
• Identification of non-obstructive plaque may identify patients at increased risk for adverse events– Ongoing prospective studies of prognosis
![Page 27: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/27.jpg)
Harvard Medical School
Angiographic vs. Functional Stenosis
Meijboom et al, J Am Coll Cardiol, 2008; 52:636-643
![Page 28: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/28.jpg)
Harvard Medical School
Outcomes after CTA
Ostrom et al, J Am Coll Cardiol, 2008; 52:1335-1343
![Page 29: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/29.jpg)
Harvard Medical School
Plaque Characterization
Leber et al, J Am Coll Cardiol, 2005; 46:147-154
![Page 30: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/30.jpg)
Harvard Medical School
Anomalous Coronary Arteries
http://bhavin.typepad.com/cardiac_images/
![Page 31: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/31.jpg)
Harvard Medical School
Anomalous Coronary Arteries
http://bhavin.typepad.com/cardiac_images/
![Page 32: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/32.jpg)
Harvard Medical School
Ventricular Function
![Page 33: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/33.jpg)
Harvard Medical School
Ventricular Function
![Page 34: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/34.jpg)
Harvard Medical School
Ventricular Function: Compared to CMR
Segung et al, Circulation 2006;114:654-661; 31 patients
![Page 35: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/35.jpg)
Harvard Medical School
Ventricular Function: Compared to CMR
Segung et al, Circulation 2006;114:654-661; 31 patients, radial method
![Page 36: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/36.jpg)
Harvard Medical School
Valvular Function
http://bhavin.typepad.com/cardiac_images/
![Page 37: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/37.jpg)
Harvard Medical School
Valvular Function
http://bhavin.typepad.com/cardiac_images/
![Page 38: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/38.jpg)
Harvard Medical School
Aortic Stenosis
Pouleur et al, Radiology 2007;244:745-754
![Page 39: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/39.jpg)
Harvard Medical School
Aortic Stenosis
Pouleur et al, Radiology 2007;244:745-754
![Page 40: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/40.jpg)
Harvard Medical School
Aortic Stenosis
Pouleur et al, Radiology 2007;244:745-754
Agreement between multidetector CT and TTE in the detection of normal (AVA 2 cm2), mildly stenotic (AVA 1.2 cm2 and < 2.0 cm2),
moderately stenotic (AVA 0.8 cm2 and < 1.2 cm2), or severely stenotic (AVA < 0.8 cm2) aortic valve opening was excellent ( = 0.88, P < .001)
![Page 41: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/41.jpg)
Harvard Medical School
Valvular Function
![Page 42: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/42.jpg)
Harvard Medical School
Valvular Dehiscence
![Page 43: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/43.jpg)
Harvard Medical School
Valvular Dehiscence
![Page 44: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/44.jpg)
Harvard Medical School
Perfusion and Late Enhancement
Nieman et al. Radiology.2008; 247: 49-56
![Page 45: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/45.jpg)
Harvard Medical School
Perfusion and Late Enhancement
Nieman et al. Radiology.2008; 247: 49-56
![Page 46: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/46.jpg)
Harvard Medical School
Perfusion and Late Enhancement
Nieman et al. Radiology.2008; 247: 49-56
![Page 47: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/47.jpg)
Harvard Medical School
Cardiac CT
• Possible indications for coronary MDCTA• How to approach a coronary MDCTA study
![Page 48: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/48.jpg)
Harvard Medical School
How to Review a Coronary CTA Study
• Review the axial images– Interrogate multiple reconstructions at different points in the
cardiac cycle to determine which has the least amount of artifact
• If any abnormalities, further investigate them with MIPs MPRs, and curved MPRs.
• Volume rendered images can be helpful to communicate your findings– Generally not diagnostic– Especially helpful in graft cases
• The entire dataset beyond the heart needs to be reviewed to ensure that there are no other significant findings.
![Page 49: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/49.jpg)
Harvard Medical School
Axial Stack
![Page 50: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/50.jpg)
Harvard Medical School
Axial Slice
![Page 51: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/51.jpg)
Harvard Medical School
MIP
![Page 52: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/52.jpg)
Harvard Medical School
Volume Rendered Image
![Page 53: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/53.jpg)
Harvard Medical School
cMPR with SAX and VA
![Page 54: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/54.jpg)
Harvard Medical School
cMPR with SAX and VA, Orthogonal
![Page 55: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/55.jpg)
Harvard Medical School
Importance of Interactive Reconstructions
Ferencik et al, Radiology: Volume 243: Number 3—June 2007
![Page 56: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center](https://reader035.vdocument.in/reader035/viewer/2022070307/551b534e550346dd1a8b6050/html5/thumbnails/56.jpg)
Harvard Medical School
Outline
• Possible indications for coronary MDCTA– Coronary artery imaging is becoming established
• Stenosis
• Plaque characterization
• Stents
• Grafts
– Ventricular function
– Aortic Stenosis
• How to approach a coronary MDCTA study– Axial images contain all of the primary data
– Use interactive reconstructions to aid in assessing problem areas